Your browser doesn't support javascript.
loading
Antitumor Immune Responses in B2M-Deficient Cancers.
Torrejon, Davis Y; Galvez, Mildred; Abril-Rodriguez, Gabriel; Campbell, Katie M; Medina, Egmidio; Vega-Crespo, Agustin; Kalbasi, Anusha; Comin-Anduix, Begoña; Ribas, Antoni.
Afiliação
  • Torrejon DY; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.
  • Galvez M; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.
  • Abril-Rodriguez G; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.
  • Campbell KM; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.
  • Medina E; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.
  • Vega-Crespo A; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.
  • Kalbasi A; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.
  • Comin-Anduix B; Department of Radiation Oncology, UCLA, Los Angeles, California.
  • Ribas A; Department of Surgery, Division of Surgical Oncology, UCLA, Los Angeles, California.
Cancer Immunol Res ; 11(12): 1642-1655, 2023 12 01.
Article em En | MEDLINE | ID: mdl-37801341
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-2 / Melanoma Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-2 / Melanoma Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2023 Tipo de documento: Article